Pharmaceuticals Drug Development Clinical Trials Gene Therapy Cell Therapy Immunotherapy Research and Development Therapeutics Oncology Drug Discovery Rare Diseases Pharmaceutical Companies Clinical Research Product Development Regulatory Affairs Diagnostics Therapies Gene Editing Vaccines Genetic Medicine Market Trends Biopharma Biosimilars RNA Therapies Complement Inhibitors Acquisitions Genmab Immunotherapeutics Novel Therapeutics Bioinformatics Theranos Obesity Treatment Corporate Actions Drug Companies Vaccine Development mRNA Technology Biotherapeutics Market Competition Contract Manufacturing AI in Medicine Market Strategy Cell and Gene Therapy Asset Tokenization Viking Therapeutics Gene Sequencing Company Announcements Genetics Regulatory Compliance Humacyte, Inc. Medical Devices Company Operations Genetic Testing Bluebird bio Inc. Companies Contract Research Organizations Biologics Moderna Biotech Companies Insulin Products Drug Delivery RNA Interference Bioprocessing Innovation
The company is securing one- to five-year contracts with customers who signal demand through 2028.
